Form 4 for OSCR Oscar Health, Inc.
Accepted 2023-11-20 00:00:00 ET · period of report 2023-11-16 · accession 0001562180-23-007799 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DT | 2023-11-20 | 2023-11-16 | OSCR | Schlosser Mario | CTO, Pres of Technology, Dir | C - Cnv Deriv | — | +390.4K | 447.7K | +681% | — |
| DT | 2023-11-20 | 2023-11-16 | OSCR | Schlosser Mario | CTO, Pres of Technology, Dir | S - Sale | $7.12 | -390.4K | 57.3K | -87% | -$2.78M |
| DMT | 2023-11-20 | 2023-11-16 | OSCR | Schlosser Mario | CTO, Pres of Technology, Dir | M - OptEx | $0.7 | 0 | 1.75M | New | $0 |
| DT | 2023-11-20 | 2023-11-16 | OSCR | Schlosser Mario | CTO, Pres of Technology, Dir | C - Cnv Deriv | — | -390.4K | 1.36M | -22% | — |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Common Stock | 2023-11-16 | C | A | 390,405 | — | 447,722 | D | — | — | (F2) The Class B common stock is convertible at any time at the option of the holder into Class A common stock on a one-to-one basis, subject to certain exceptions, and will mandatorily convert into Class A common stock on the date that is seven years from the date of the prospectus used in connection with the Issuer's initial public offering and upon the occurrence of certain events as set forth in the Issuer's certificate of incorporation. |
| 2 | Common | Class A Common Stock | 2023-11-16 | S | D | 390,405 | $7.12 | 57,317 | D | — | — | (F4) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.99 to $7.24, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected. |
| 3 | Derivative | Stock Option (Right to Buy) | 2023-11-16 | M | D | 608,430 | $0.00 | 0 | D | $1.40 · — to 2024-01-17 | 608,430 Class B Common Stock | (F5) The stock option is fully vested and exercisable, and expires on January 17, 2024. |
| 4 | Derivative | Class B Common Stock | 2023-11-16 | M | A | 608,430 | $1.40 | 1,745,543 | D | — · — to — | 608,430 Class A Common Stock | (F2) The Class B common stock is convertible at any time at the option of the holder into Class A common stock on a one-to-one basis, subject to certain exceptions, and will mandatorily convert into Class A common stock on the date that is seven years from the date of the prospectus used in connection with the Issuer's initial public offering and upon the occurrence of certain events as set forth in the Issuer's certificate of incorporation. |
| 5 | Derivative | Class B Common Stock | 2023-11-16 | C | D | 390,405 | — | 1,355,138 | D | — · — to — | 390,405 Class A Common Stock | (F2) The Class B common stock is convertible at any time at the option of the holder into Class A common stock on a one-to-one basis, subject to certain exceptions, and will mandatorily convert into Class A common stock on the date that is seven years from the date of the prospectus used in connection with the Issuer's initial public offering and upon the occurrence of certain events as set forth in the Issuer's certificate of incorporation. |